Thrivent Financial for Lutherans’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-410,483
| Closed | -$2.49M | – | 2285 |
|
|
2019
Q3 | $2.49M | Sell |
410,483
-56,635
| -12% | -$343K | 0.01% | 893 |
|
|
2019
Q2 | $3.03M | Buy |
467,118
+169
| +0% | +$1.1K | 0.01% | 818 |
|
|
2019
Q1 | $3.31M | Buy |
466,949
+212
| +0% | +$1.5K | 0.01% | 784 |
|
|
2018
Q4 | $2.27M | Sell |
466,737
-68,729
| -13% | -$334K | 0.01% | 794 |
|
|
2018
Q3 | $3.94M | Sell |
535,466
-64,543
| -11% | -$474K | 0.01% | 707 |
|
|
2018
Q2 | $3.83M | Buy |
600,009
+3,247
| +0.5% | +$20.7K | 0.01% | 718 |
|
|
2018
Q1 | $3.25M | Buy |
596,762
+7,792
| +1% | +$42.4K | 0.01% | 749 |
|
|
2017
Q4 | $2.46M | Hold |
588,970
| – | – | 0.01% | 842 |
|
|
2017
Q3 | $5.67M | Buy |
588,970
+62,110
| +12% | +$598K | 0.02% | 573 |
|
|
2017
Q2 | $6.23M | Buy |
526,860
+208,000
| +65% | +$2.46M | 0.03% | 512 |
|
|
2017
Q1 | $4.09M | Buy |
318,860
+21,210
| +7% | +$272K | 0.02% | 636 |
|
|
2016
Q4 | $3.64M | Buy |
+297,650
| New | +$3.64M | 0.02% | 679 |
|